| Q58462029 | Cytokine and coagulation characteristics of retrieved blood after arthroplasty |
| Q37631956 | Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs |
| Q34282732 | Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers. |
| Q35364689 | Fibrinolytic mechanisms in tumor growth and spreading |
| Q37200930 | Hyperfibrinolysis in hepatosplenic schistosomiasis |
| Q51580657 | Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients. |
| Q72927619 | Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex |
| Q33801932 | Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know |
| Q68026189 | Monitoring prothrombin fragment 1 + 2 during initiation of oral anticoagulant therapy after intracoronary stenting |
| Q73295920 | No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation |
| Q58829366 | Post-meal coagulation activation in diabetes mellitus: the effect of acarbose |
| Q72221860 | Procoagulant activity and intimal dysfunction in IDDM |
| Q73897052 | Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders |
| Q71377364 | Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate |
| Q73681264 | Thrombin: Structure, Biochemistry, Measurement, and Status in Clinical Medicine |